1. Zelenetz AD, Abramson JS, Advani RH, et al. 2010; NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas. J Natl Compr Canc Netw. 8:288–334. DOI:
10.6004/jnccn.2010.0021. PMID:
20202462.
2. Sah SP, Matutes E, Wotherspoon AC, Morilla R, Catovsky D. 2003; A comparison of flow cytometry, bone marrow biopsy, and bone marrow aspirates in the detection of lymphoid infiltration in B cell disorders. J Clin Pathol. 56:129–32. DOI:
10.1136/jcp.56.2.129. PMID:
12560392. PMCID:
PMC1769888.
3. Okaly GV, Nargund AR, E V, Jayanna PK, Juvva CR, Prabhudesai S. 2013; Chronic lymphoproliferative disorders at an Indian tertiary cancer centre - the panel sufficiency in the diagnosis of chronic lymphocytic leukaemia. J Clin Diagn Res. 7:1366–71. DOI:
10.7860/JCDR/2013/5088.3130. PMID:
23998067. PMCID:
PMC3749637.
4. Fineberg S, Marsh E, Alfonso F, et al. 1993; Immunophenotypic evaluation of the bone marrow in non-Hodgkin's lymphoma. Hum Pathol. 24:636–42. DOI:
10.1016/0046-8177(93)90244-B. PMID:
8505041.
5. Horny HP, Wehrmann M, Griesser H, Tiemann M, Bültmann B, Kaiserling E. 1993; Investigation of bone marrow lymphocyte subsets in normal, reactive, and neoplastic states using paraffin-embedded biopsy specimens. Am J Clin Pathol. 99:142–9. DOI:
10.1093/ajcp/99.2.142. PMID:
8438787.
6. Bluth RF, Casey TT, McCurley TL. 1993; Differentiation of reactive from neoplastic small-cell lymphoid aggregates in paraffin-embedded marrow particle preparations using L-26 (CD20) and UCHL-1 (CD45RO) monoclonal antibodies. Am J Clin Pathol. 99:150–6. DOI:
10.1093/ajcp/99.2.150. PMID:
7679873.
7. Hendry S, Salgado R, Gevaert T, et al. 2017; Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immuno-oncology biomarkers working group: Part 2: TILs in melanoma, gastrointestinal tract carcinomas, non-small cell lung carcinoma and mesothelioma, endometrial and ovarian carcinomas, squamous cell carcinoma of the head and neck, genitourinary carcinomas, and primary brain tumors. Adv Anat Pathol. 24:311–35. DOI:
10.1097/PAP.0000000000000161. PMID:
28777143. PMCID:
PMC5638696.
9. Dewan K, Mann N, Chatterjee T. 2015; Comparing flow cytometry immunophenotypic and immunohistochemical analyses in diagnosis and prognosis of chronic lymphoproliferative disorders: experience from a Tertiary Care Center. Clin Cancer Investig J. 4:707–12. DOI:
10.4103/2278-0513.165524.
10. Leers MP, Theunissen PH, Ramaekers FC, Schutte B, Nap M. 2000; Clonality assessment of lymphoproliferative disorders by multiparameter flow cytometry of paraffin-embedded tissue: an additional diagnostic tool in surgical pathology. Hum Pathol. 31:422–7. DOI:
10.1053/hp.2000.6551. PMID:
10821487.
11. Abdel-Ghafar AA, El Din El Telbany MA, Mahmoud HM, El-Sakhawy YN. 2012; Immunophenotyping of chronic B-cell neoplasms: flow cytometry versus immunohistochemistry. Hematol Rep. 4:e3. DOI:
10.4081/hr.2012.e3. PMID:
22567217. PMCID:
PMC3343452.